Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

This Phase 3 trial is evaluating deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis, assessing efficacy, safety, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Deucravacitinib (deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Plaque Psoriasis | Phase 3 | Status: RECRUITING